Your session is about to expire
← Back to Search
3BNC117-LS + 10-1074-LS for HIV
Study Summary
This trial will evaluate if HIV-suppressing drugs 3BNC117-LS and 10-1074-LS are safe and reduce the number of HIV-infected blood cells in people with HIV on antiretroviral therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not had an AIDS-defining illness in the last 3 years.I have not received any non-HIV vaccines in the last 2 weeks.I have received HIV-1 antibody therapy or an HIV vaccine.I haven't taken steroids, immunosuppressants, or certain cancer treatments in the last 6 months.I am willing and able to follow all study procedures for its entire duration.I am between 18 and 70 years old.I am not pregnant and cannot become pregnant due to surgery or my partner's vasectomy.I have HIV-1 and my condition is stable.I started antiretroviral therapy soon after my infection was diagnosed.I am on HIV treatment with low virus levels and no breaks in my treatment for over 2 years.I cannot undergo leukapheresis due to poor vein access or other health issues.I have hepatitis B or C, or had hepatitis C but now test negative for the virus.
- Group 1: 3BNC117-LS and 10-1074-LS
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is eligible to join this research study?
"This medical trial is searching for 100 volunteers who are between 18 and 70 years old, with a positive diagnosis of HIV-1."
How risky are 3BNC117-LS and 10-1074-LS treatments for patients?
"3BNC117-LS and 10-1074-LS have both been awarded a score of 1 due to the lack of data concerning their safety and efficacy, as this is only a Phase 1 trial."
Does the age restriction of this research extend beyond seventy-five years?
"This clinical trial is open to any individual aged 18 or over, but no older than 70 years."
Are enrollments still available for this experiment?
"Based on information sourced from clinicaltrials.gov, this medical trial is no longer seeking patients. Initially posted November 29th 2022 and last edited on the 23rd of that same month, 10 other trials remain open for enrollment at present."
Share this study with friends
Copy Link
Messenger